FDA Inspection 1229376 — Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)
The FDA completed an inspection of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) on Jan 16, 2024 in Lianyungang. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jan 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)